Catalyst Pharmaceuticals Announces Second Quarter 2021 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. HOOD
8. DFTX
9. MU
10. IBM

Go back to Catalyst Pharmaceuticals Announces Second Quarter 2021 Financial Results and Provides Corporate Update

Catalyst Pharmaceuticals (CPRX) Tops Q2 EPS by 8c

August 9, 2021 4:45 PM EDT

Catalyst Pharmaceuticals (NASDAQ: CPRX) reported Q2 EPS of $0.17, $0.08 better than the analyst estimate of $0.09. Revenue for the quarter came in at $36.4 million versus the consensus estimate of $31.51 million.

For earnings history and earnings-related data on Catalyst Pharmaceuticals (CPRX) click here.

... More